Q3 FY2026 call
FetchingEdwards Lifesciences Corporation reported on November 4, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
$107.19+1.3%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 4, 2026
Edwards Lifesciences sells catheter-delivered heart valves and repair devices, plus surgical replacement valves, to hospitals treating people with heart valve disease.
Company outlook: revenue of $1.7B to $1.8B for Fiscal Q4 2026 — up 8.9% on a year earlier
Just reported
From Edwards Lifesciences Corporation's results release of November 4, 2026; its quarterly report has since been filed.
Actual
$1.72B
+10% y/y
-1.5% q/q
Guided
$1.67B
midpoint
Actual
$0.53
+6.0% y/y
+26% q/q
Guided
—
| Measure | 3 months toSep 30, 2026 | 3 months toSep 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $1.7B | $1.6B | +10.46% |
| Profit | $307.5M | $291.1M | +5.63% |
| Profit per share | $0.53 | $0.50 | +6.00% |
| Free Cash Flow | $506.7M | $516.2M | -1.84% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
A short summary of each call — what the quarter showed, what management expects and whether they delivered on what they said last time — with the full transcript underneath.
Edwards Lifesciences Corporation reported on November 4, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
“We delivered strong third-quarter growth of 11.2% which exceeded expectations, with broad-based performance across our businesses and regions, giving us the confidence to raise our full-year outlook,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube. Conference Call and Webcast Information The company will be hosting a conference call today at 2:00 p.m. PT to discuss its third quarter results. To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the “
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Edwards Lifesciences Corporation’s Item 2.02 8-K filed November 4, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
No guide given
Actual
$299.1M
-2.6% y/y
-42% q/q
Guided
—
No guide given
Q4 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Summaries of earlier calls are part of Pro.
Summaries of earlier calls are part of Pro.
Summaries of earlier calls are part of Pro.
Source: Yahoo Finance, transcribed by Quartr. Speaker names and roles are as transcribed; analysts are sometimes unnamed.
Call summaries are part of Pro
A two-minute read of every Edwards Lifesciences Corporation earnings call: the numbers that mattered, what management expects, whether they delivered on last quarter’s outlook, and what analysts asked that went unanswered.
See one first on , , , or — open to everyone.
Summaries of earlier calls are part of Pro.
Summaries of earlier calls are part of Pro.